Vaccine-enhanced competition permits rational bacterial strain replacement in the gut
Authors:
- Verena LentschVLVerena Lentsch
- Andrea RockerARAndrea Rocker
- Claudia MoresiCMClaudia Moresi
- Niina RuohoNRNiina Ruoho
- Louise LarssonLLLouise Larsson
- Stefan A. FattingerSFStefan A. Fattinger
- Nicolas WennerNWNicolas Wenner
- Elisa Cappio BarazzoneEBElisa Cappio Barazzone
- Wolf-Dietrich HardtWHWolf-Dietrich Hardt
- Claude LoverdoCLClaude Loverdo
Preprint
Abstract
Widespread antimicrobial resistance generates an urgent need to develop better disease prophylaxis for intestinal bacterial pathogens. While the first phase of infection with any bacterial pathogen is typically colonization of the mucosal surfaces, current vaccine strategies typically target invasive stages of disease. Here we demonstrate the ability to specifically generate sterilizing immunity against Salmonella enterica subspecies enterica serovar Typhimurium (S.Tm) at the level of gut lumen colonization using a combination of oral vaccination and a rationally-designed niche competitor strain. This is based on the proven ability of specific secretory IgA to generate a fitness disadvantage for a targeted bacterium, allowing a non-targeted competitor to rapidly overtake its niche. By hugely decreasing the population size of an intestinal pathogen during the early stages of infection, this improves protection of gut tissue compared to standard licensed animal vaccines. We demonstrate that most effective protection is generated when the niche competitor is derived from the pathogen and therefore occupies an identical niche. However, as this is unrealistic in real-world infections, we further demonstrate that robust protection can also be generated with a more distantly related “probiotic” niche competitor from a distinct species. Interestingly, focusing prophylaxis on the gut lumen reveals an uncoupling of protective mechanisms required for protection in the gut and gut tissues and those required for protecting against colonization of the spleen and liver. Therefore, while there is still potential to improve this approach by adding systemic immune activation, we nevertheless believe this is a fundamental step forward in our ability to manipulate colonization of intestinal bacteria with potential application to a wide-range of entero-pathogens, as well as to manipulation of microbiota composition.Keywords
All Related Versions
- Published version: Science, 388 (6742), 74.
This publication has 52 references indexed in Scilit:
- Lymph Node Colonization Dynamics after Oral Salmonella Typhimurium Infection in MicePLOS Pathogens, 2013
- Stabilization of cooperative virulence by the expression of an avirulent phenotypeNature, 2013
- The intestinal fatty acid propionate inhibits Salmonella invasion through the post‐translational control of HilDMolecular Microbiology, 2013
- Gut inflammation can boost horizontal gene transfer between pathogenic and commensal EnterobacteriaceaeProceedings of the National Academy of Sciences, 2012
- Host Transmission of Salmonella enterica Serovar Typhimurium Is Controlled by Virulence Factors and Indigenous Intestinal MicrobiotaInfection and Immunity, 2008
- Salmonella entericaSerovar Typhimurium Pathogenicity Island 2 Is Necessary for Complete Virulence in a Mouse Model of Infectious EnterocolitisInfection and Immunity, 2005
- Characterization of Salmonella enterica Derivatives Harboring Defined aroC and Salmonella Pathogenicity Island 2 Type III Secretion System ( ssaV ) Mutations by Immunization of Healthy VolunteersInfection and Immunity, 2002
- ColE1-type vectors with fully repressible replicationGene, 1991
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981
- Colonization resistance of the digestive tract in conventional and antibiotic-treated miceEpidemiology and Infection, 1971